buoyantintelligence
  • 01Overview
  • 02Portfolio
  • 03Company Atlas
    • Buoyant book
    • All listed companies
  • 04Screener & valuation
  • 05House view
  • 06Markets
  • 07India top-down
  • 08Investors
  • 09Library & data
Release
August 2026 · rev 1
Opportunities PMS · Published
As at 31 Aug 2026 · IST₹ · ₹ cr · BSE 500 TRI
Present
Internal working platform. Published figures are extracted from the August 2026 source package and reviewed; reference prices and fundamentals are unlicensed working data, not for redistribution. Past performance is not indicative of future returns.
All listed companies/Sai Life Sciences Limited
03 /Listed universe · Healthcare · CDMO

Sai Life Sciences Limited.

Value itCompareScreener.in ↗Tijori ↗NSE ↗BSE ↗
Snapshot

Healthcare · CDMO

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.

Market cap
₹33,963 cr
P/E (TTM)
94.7
P/B (latest)
13.7
ROE (TTM)
14.1%
ROCE (TTM)
18.4%
Sales CAGR 3y
21.7%
PAT CAGR 3y
226%
Debt / equity
0.04x
Promoter
34.5%
Dividend yield
—
Size
Small
Codes
SAILIFE · 544306
Price

₹1,582.8 · 28 Sept 2026

1M
+6.6%
3M
+29.6%
6M
+60.6%
YTD
+75.8%
1Y
+84.4%
3Y
—
5Y
—
vs 52w high
−5.5%

52-week ₹795 – ₹1,675.4 · ADTV ₹89.2 cr · price-only.

Trend

Sales and net profit by fiscal year, ₹ crore

Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ